Respiratorius AB

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
97,6
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Anna Törner
  • Johan Drott
  • Kristina Drott
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Presentation Stora Aktiedagen Stockholm 2017-11-13

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 8,28 8,28 2024-03-26
    Valcuria Holding AB 3,86 3,86 2024-03-26
    Ben Hayes 2,32 2,32 2024-03-26
    Hans Harvig 1,72 1,72 2024-03-26
    Hans Mandahl 1,20 1,20 2024-03-26
    Benny Bengtsson 1,09 1,09 2024-03-26
    Göran Lennart Rehn 0,99 0,99 2024-03-26
    Hartmut Wiese 0,99 0,99 2024-03-26
    Christian Müller 0,99 0,99 2024-03-26
    Nordnet Pensionsförsäkring 0,90 0,90 2024-03-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2024-05-21 Årsstämma 2023

    • 2024-05-21 Delårsrapport 2024-Q1

    • 2024-08-06 Delårsrapport 2024-Q2

    • 2024-11-12 Delårsrapport 2024-Q3

    • 2025-02-11 Bokslutskommuniké 2024

    Annual reports, prospectus etc.